CDSCO to issue show cause notices to unlicensed manufacturers of orthopedic implants

Image
Press Trust of India New Delhi
Last Updated : Mar 16 2019 | 10:25 PM IST

The Central Drugs Standard Control Organization (CDSCO) will be soon issuing show cause notices to 29 firms and five traders who were found manufacturing and selling orthopedic implants without licences in recent raids.

According to a CDSCO official, these plants were found violating the norms under the Drugs and Cosmetics Act and Rules, 2018 in the selling and manufacturing of orthopedic implants.

"We are in the process of issuing show cause notices to these firms and traders and working on the details of the firms," the official said Saturday.

On March 11, inspectors at CDSCO conducted raids at 45 medical devices plants in four states, and found 29 of them and five traders manufacturing or selling orthopedic implants without licence or approval.

Further many of the units were using substandard material in unclean conditions, officials said.

Twenty-five firms were raided in the national capital, while searches were carried out in eight such facilities in Maharashtra, a senior official said, adding six firms each in Gujarat and Uttar Pradesh were also raided in a joint operation with officials of the states concerned.

"In the last two months, the CDSCO's intelligence cell gathered information from across the country regarding manufacture of various orthopedic implants without licences.

"It received information that a large number of unlicensed manufacturing activities were being carried out in Delhi, Uttar Pradesh, Gujarat and Maharashtra. Based on this information, the raids were carried out," the official said.

The intelligence cell at CDSCO was constituted in March, 2018. During raids, the officials found that the manufacturers did not hold valid licences and the devices were being made using substandard material in unclean conditions.

It was also found that the firms did not have quality management systems in place as is required under the Medical Devices Rules. Neither did the facilities conduct laboratory tests. Also they were just assembling the products and terming it as being manufactured by them, the official added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 16 2019 | 10:25 PM IST

Next Story